Tall Oaks Capital Partners

What Tall Oaks Capital Partners does

Tall Oaks Capital Partners, LLC is a privately held venture capital firm founded in 2000 and domiciled in Delaware, headquartered at 315 Old Ivy Way, Suite 301, Charlottesville, Virginia. The firm specializes in seed and early-stage investments in healthcare (including biotechnology, medical devices, and healthcare IT) and information technology (including software, security, and enterprise solutions), with a stated geographic focus on the Mid-Atlantic and Southeastern United States. It is led by four founding partners — Kathryne Carr, Hi (Hiram) Ewald, Jim Farinholt, and Reenst Lesemann — supported by an administrative lead (Colin Rolph) and a Strategic Advisory Board, with the partners collectively claiming more than 125 years of seed and early-stage investment and corporate experience.

The firm's investment model is proactive and long-term: it writes initial checks of $50,000 to $1,500,000 and then provides hands-on company-building support, including executive recruitment, corporate partnership facilitation, and follow-on capital. Tall Oaks co-invests with over 45 firms and is a member of the Village Ventures network — 13 geographically focused early-stage partner funds and 45 professional managers funded by Bain Capital, Highland Capital, Janus, and Sandler Capital. It also maintains formal supportive arrangements with three leading research universities in the region and a partnership with SURA under the SURAFund initiative for university spin-off commercialization. Revenue is generated through venture capital returns (carried interest from exits, IPOs, and acquisitions) and fund management fees, with no public disclosure of AUM or management fee economics.

Disclosed portfolio activity through 2009 includes Biolex Therapeutics (Series C $30M in 2007, Series D $60M in 2008), nContact Surgical (Series B $7.5M in 2006), GetWellNetwork ($9M Series B in 2006 and $10M financing in 2009), Living MicroSystems ($5.3M Series A), Aldagen (IPO filing May 2008), Biolex (IPO filing August 2007), nCircle (acquisition of Cambia in 2007), and ScholarOne (acquired by Thomson in 2006). The website's news archive runs through mid-2009, and there is no evidence in the supplied data of subsequent fund vintages or active updates, which is a material data gap for current-state assessment.

Name

Tall Oaks Capital Partners

Legal name

Tall Oaks Capital Partners, LLC

Website

https://talloakscapital.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

1–10 employees

Short description

Tall Oaks Capital Partners is a privately held, Charlottesville, Virginia-based venture capital firm founded in 2000 that makes seed and early-stage investments of $50,000 to $1,500,000 in healthcare and information technology companies across the Mid-Atlantic and Southeastern United States, leveraging the Village Ventures network and co-investing with over 45 firms.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Portfolio Management and Investment Advice (52394), Other Investment Pools and Funds (5259)

SIC

Investment Advice (6282)

akta.pro primary industry

Micro-VC & Angel Funds (FSANAAAI)

akta.pro secondary industry

Emerging Managers / Seeding Platforms (FSAHAKAI)

Keywords

• Venture capital investments
• Seed stage funding
• Early stage capital
• Healthcare investments
• Information technology investing

Headquarters

HQ city

Charlottesville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Venture Capital Returns: Returns generated from successful portfolio companies through exits, including IPOs, acquisitions, and other liquidity events. The firm invests in seed and early-stage companies and provides ongoing strategic guidance to help companies grow and achieve milestones.
2. Fund Management: Management of venture capital funds with investments ranging from $50,000 to $1,500,000 per company, co-investing with other VC firms and leveraging the Village Ventures network.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Tall Oaks Capital Partners is a venture capital firm that provides seed and early-stage equity investments ranging from $50,000 to $1,500,000 per company, alongside long-term strategic guidance and company-building support. The firm focuses on entrepreneurial teams in the healthcare and information technology sectors in the Mid-Atlantic and Southeastern U.S., leveraging partnerships with research universities and the Village Ventures network of 13 partner funds.

Product overview

Tall Oaks Capital Partners is a venture capital firm, not a technology product company. The firm focuses on seed and early stage investments in healthcare and information technology sectors in the Mid-Atlantic and Southeastern U.S. regions. Their business model centers on providing investment capital and strategic guidance to entrepreneurial companies rather than offering technology products or services. The firm does not develop, sell, or license technology products to customers.

Differentiator

Problem solved

Functional benefit

Products and services

• Seed and Early-Stage Equity Investment Equity capital deployments ranging from $50,000 to $1,500,000 per company in seed and early-stage businesses in healthcare and information technology, with pro-active long-term support. Target users are founders and management teams of early-stage companies in the Mid-Atlantic and Southeastern U.S.
• Strategic Company-Building Guidance Long-term strategic support including executive recruitment, corporate partnership facilitation, milestone achievement coaching, and risk mitigation for portfolio companies. Target users are portfolio company founders and management teams.
• SURAFund University Spin-off Investment Program Program to identify, fund, and support university-derived technology spin-offs in partnership with the Southeastern Universities Research Association. Target users are research universities and their spin-off companies in the Mid-Atlantic and Southeastern U.S.

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

14 partnerships are on record, tiered minor and core.

• MicrosoftminorStrategic or Co-development Partner · 14 October 2008nCircle, a Tall Oaks portfolio company, partnered with Microsoft to protect customers through security solutions integration.
• Adventist Health SystemcoreChannel Partner/ Reseller/ Distributor · 15 September 2008GetWellNetwork Signs Agreement with Adventist Health System as Exclusive Provider of Interactive Patient Care (IPC).
• Merck KGaAcoreStrategic or Co-development Partner · 19 February 2008Biolex Therapeutics Enters into Agreement with Merck KGaA for Antibody Optimization.
• BinexminorStrategic or Co-development Partner · 28 November 2007Binex and MaxCyte Collaborate on Cancer Immunotherapy Research.
• WiprominorStrategic or Co-development Partner · 30 October 2007Wipro Standardizes on Relativity Technologies for software solutions.
• MerialcoreStrategic or Co-development Partner · 1 May 2007Biolex Therapeutics Announces Strategic Collaboration with Merial - first vaccines to be produced with LEX System.
• OracleminorStrategic or Co-development Partner · 21 March 2007Relativity Technologies, a Tall Oaks portfolio company, teams with Oracle for enterprise solutions.
• American Hospital AssociationcoreStrategic or Co-development Partner · 26 February 2007GetWellNetwork Endorsed by the American Hospital Association.
• IBMminorStrategic or Co-development Partner · 23 February 2007Persystent Technologies, a Tall Oaks portfolio company, announces OEM agreement with IBM.
• Southeastern Universities Research Association (SURA)coreStrategic or Co-development Partner · 4 October 2006SURA to Connect University Spin-offs with Investment Capital. Tall Oaks Partners with SURA for the SURAFund initiative supporting university technology commercialization.
• GT SoftwareminorStrategic or Co-development Partner · 21 June 2006Partnership Announced with GT Software to Support SOA Initiatives.
• CybertrustminorStrategic or Co-development Partner · 5 June 2006nCircle and Cybertrust Announce Strategic Partnership for security solutions.
• U.S. General Services Administration (GSA)minorStrategic or Co-development Partner · 31 May 2006U.S. General Services Administration Modernizes with Relativity Technologies.
• MedarexcoreStrategic or Co-development Partner · 11 April 2006Biolex Therapeutics Announces Expansion Of Medarex Collaboration for therapeutic development.

Scale indicators4 records

Recent moves10 records

Expansion highlights4 records

Direct peers

• Edison Partners: Mid-Atlantic (Princeton, NJ)-based growth and later-stage VC firm investing in technology and healthcare. Comparable as a regional VC with similar healthcare/IT focus and Mid-Atlantic orientation, though Edison writes larger checks than Tall Oaks.
• Noro-Moseley Partners: Atlanta-based early-stage VC firm focused on healthcare IT, tech-enabled services, and B2B software across the Southeast. Directly comparable in geography (Southeast emerging markets), stage (seed/early), and sector mix (healthcare + IT).
• Council Capital: Nashville-based healthcare-focused VC firm investing in growth-stage services and tech-enabled healthcare companies. Comparable as a regional Southeast VC with deep healthcare sector specialization.
• MB Venture Partners: Memphis, TN-based venture capital firm focused on medical devices, healthcare services, and technology. Directly comparable in Southeast geography and healthcare/tech sector focus with similar check-size range.
• CIT GAP Fund: Virginia-based seed and early-stage investment fund managed by the Center for Innovative Technology, investing in Virginia-affiliated technology and life science companies. Closely comparable as a Virginia-rooted seed/early VC with overlapping deal flow through Virginia universities.

Regional players

• Harbert Venture Partners: Birmingham, Alabama-based venture and growth capital firm (formerly Intersouth Partners) investing in technology and life sciences across the Southeast. Comparable as a Southeast regional VC with overlapping portfolio themes.
• TCP Venture Capital: Virginia-based early-stage venture capital firm affiliated with the Virginia Tech Corporate Research Center, investing in technology and life sciences. Comparable as a Virginia-rooted early-stage VC with university tech-transfer deal flow.

Others

• Village Ventures: The multi-manager venture platform of which Tall Oaks is a partner fund, managing 13 geographically focused early-stage partner funds backed by Bain Capital, Highland Capital, Janus, and Sandler Capital. Comparable as the parent/sister platform providing back-office, deal flow, and co-investment support.

Broad incumbents

• New Enterprise Associates (NEA): One of the largest US venture capital firms (Chevy Chase, MD) investing across stages and sectors including healthcare and IT. Comparable as a major Mid-Atlantic incumbent with overlapping healthcare and IT theses, but at vastly larger fund and check sizes.
• Domain Associates: Princeton, NJ-based healthcare-focused VC firm investing across all stages of therapeutics, medical devices, and diagnostics. Comparable in Mid-Atlantic geography and healthcare sector focus, but with a much larger fund and broader stage mandate.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/atricure
• Facebookfacebook.com/atricure

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments13 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tall Oaks Capital Partners